BISTTRY16:21Live
GENIL Ratio Analysis: P/E, P/B, EV/EBITDAGen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş.
Main MarketChemicals, Petroleum, Rubber and Plastics
3.30−0.19 (−5.44%)
- Volume
- TRY 178.2M
- Day range
- 3.16 – 3.51
- Previous close
- 3.49
- Market cap
- TRY 14.8B
Last updated: Source: Borsa Istanbul, 15-minute delayed
35 key ratios for Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş. (GENIL) computed from the latest financial statements and the current price: valuation, profitability, liquidity, leverage and efficiency.
Ratio Analysis
| P/E | 12.24 |
| P/B | 1.08 |
| EV/EBITDA | 5.61 |
| Dividend yield | 0.17% |
| Beta | — |
| Earnings per share | 0.3 TL |
| Book value per share | 3.1 TL |
| EBITDA | 3.7B TL |
| Net profit | 1.1B TL |
| Operating profit | 3.2B TL |
| Operating profit before finance costs | 3B TL |
| Net working capital | 2.8B TL |
| Gross margin | 27.52% |
| Operating margin | 15.42% |
| Net margin | 5.17% |
| Return on assets | 4.69% |
| Return on equity | 9.10% |
| Current ratio | 1.23 |
| Quick ratio | 1.03 |
| Cash ratio | — |
| Leverage ratio | 50.03 |
| Debt to equity | 1.00 |
| Debt to assets | 0.50 |
| Fixed assets to equity | 0.93 |
| Short-term debt share | 0.37 |
| Interest coverage | — |
| Receivables turnover | 1.28 |
| Days sales outstanding | 285 |
| Inventory turnover | 6.04 |
| Days inventory outstanding | 60 |
| Payables turnover | 2.74 |
| Days payables outstanding | 133 |
| Working capital turnover | 7.36 |
| Equity turnover | 1.49 |
| Asset turnover | 0.74 |
Frequently Asked Questions
What is the P/E ratio of GENIL?
GENIL has a P/E ratio of 12.24, a P/B ratio of 1.08 and an EV/EBITDA of 5.61.
When are the ratios updated?
Price-based ratios (P/E, P/B, EV/EBITDA, dividend yield) refresh daily; balance-sheet ratios refresh after the company publishes its KAP financial report.